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0883-9441/© 2017 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oAvailable online xxxx Purpose: Knowledge of families' perspective of quality of intensive care unit (ICU) care is important, especially
with regard to end-of-life (EOL) care. Adaptation of the US-developed “Quality of dying and death questionnaire”
(QODD) to a European setting is lacking. The primary aim of this study is to examine the euroQODD's usability
and its assessments of EOL care in a cohort of Danish and Dutch family members.
Methods: Family members of patients dying in an ICU after a stay of at least 48 h were sent the euroQODD three
weeks after the patient died. Selected patient characteristics were obtained from hospital records. A total of 11
Danish and 10 Dutch ICU's participated.
Results: 217 family members completed the euroQODD part of the euroQ2 questionnaire. Overall rating of care
was high, a median of 9 in Netherlands and 10 in Denmark on a 0–10 scale (p b 0.001). The Danish were more
likely to report adequate pain control all or most of the time (95% vs 73%; p b 0.001). When decisions were
made to limit treatment, the majority of family members agreed (93%). Most (92%) reported some participation
in the decision-making, with half (50%) making the decision jointly with the doctor. About 18% would have pre-
ferred greater involvement. Factor analysis identiﬁed a six-indicator unidimensional quality of dying and death
construct with between-country measurement invariance. However, in its current form the euroQODD instru-
ment requires modeling the six items as reﬂective (or effect) indicators, when they are more accurately con-
ceived as causal indicators.
Conclusions: Themajority of familymembers were satisﬁedwith the quality of EOL care and quality of dying and
death. They agreed with decisions made to limit treatment andmost felt they had participated to some extent in
decision-making, although somewould have preferred greater participation. Addition of items that can be accu-
rately treated as effect indicators will improve the instrument's usefulness in measuring the overall quality of
dying and death.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
End of life care
ICU
Quality of dying
Family
euroQODD
euroQ21. Introduction
Caring for the dying patient is part of critical care, and the quality of
that care affects not only the patient but his/her family. As the primary
goal of treatment switches from cure to comfort, families oftenare Medicine, Medical Center
erlands.
anne.irene.jensen@rsyd.dk
@u.washington.edu (J.R. Curtis),
Hofhuis), rengel@uw.edu
ra@umcg.nl (J.G. Zijlstra).
. This is an open access article underexperience stress as theymay be asked to participate inmaking difﬁcult
decisions to guide care and as they anticipate the loss of their loved one
[1,2]. As ICU clinicians, we have an important responsibility for provid-
ing good end-of life care to patients and their families. Reliable mea-
surement of the quality of end-of-life care is crucial to identify what
goes well and where improvements are needed.
Due to the severity of their illness, ICUpatients are rarely able to pro-
vide assessments of the care they are receiving, and familymembers be-
come surrogates for these assessments. Family members' assessments
of the quality of patient care have been found to correlate well with pa-
tient assessments in non-terminal care, providing support for their use
in evaluating end-of-life care provided to critically ill patients [2,3].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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measure the perceived quality of ICU care in general such as the Family
Satisfaction in the ICU (FS-ICU) [4]. Others focus on end-of-life care such
as the Quality of Dying and Death (QODD) questionnaire developed in
the US [5]. The QODD has previously been tested in the Netherlands
[6]. Several items had a high rate of missing values, and some items
were not seen as relevant by family members. Therefore, we conducted
a Danish-Dutch study to develop a new measurement tool, more suit-
able for our population. The new questionnaire was based on both the
FS-ICU and the QODD, of which six questions were used. This was
done in close cooperation with the original developers. Because
decision-making is a very important part of end-of- life care, we
added questions about the family perceptions of the decision making
process. We also included a question about the role family members
wanted to play in decision-making. With these new questions, the
euroQODD might add to the body of knowledge about family
preferences.
This combination of the euroFS-ICU and the euroQODD is called the
“European Quality Questionnaire” (euroQ2). Earlier quantitative valida-
tion showed high content and face validity [7]. In the current study we
report the results of our analysis of the euroQODD part of the euroQ2
questionnaire. Our primary goal was to report response patterns from
the two countries to euroQODD questions, with tests for between-
country differences, and to evaluate the accessibility of the questions
to respondents from the two countries. In addition, we have provided
an initial evaluation of whether the instrument in its current form
showspromise for identifying anunderlying latent construct that repre-
sents patients' overall quality of dying and death.
2. Methods
2.1. Instrument
The euroQ2 questionnaire (available as supplementalmaterial) con-
sists of two sections: the euroFS-ICU,whichwas completed by all partic-
ipating family members; and the euroQODD, which was completed by
family members of patients who died in the ICU. In this article, we re-
port on the 14 questions that compose the euroQODD questionnaire.
2.2. Design and setting
Participants were from 21 ICUs in The Netherlands (n = 10) and
Denmark (n = 11). ICUs in both countries included university-
afﬁliated and regional ICUs, with the centers situated in different parts
of the countries. This prospective study was performed during a 10-
month period from October 2014 until June 2015.
2.3. Inclusion and exclusion criteria
Family members of consecutive patients who died in an ICU after a
stay of at least 48 h were eligible for study participation. Up to three
family members per patient (including partners, children, siblings, par-
ents and close friends) were identiﬁed by the patient (if able) or staff
during the patient's hospitalization and received invitations to partici-
pate. Family members under the age of 18, those with cognitive impair-
ment and thosewhowere unable to read orwrite Dutch or Danishwere
excluded.
2.4. Recruitment of participants
Family members received oral and written information about the
study and were asked for consent to participate after their loved one
died. Three weeks after the patient died in the ICU, family members
were sent the euroQ2 questionnaire by regularmail, togetherwithwrit-
ten information and a pre-paid envelope. In the Netherlands all ques-
tionnaires were sent out by the investigators; in Denmark theindividual ICUs distributed the questionnaires. In both countries, all
the completed questionnaires were returned to the investigators. If
the questionnaire was not returned, a reminder with a new question-
naire was posted once after two weeks.
2.5. Patient and respondent data
Patient data were obtained from medical records and included gen-
der, age, reason for admission (respiratory illness, cardiovascular illness,
sepsis, or other condition), length of stay in the ICU, SAPS (Simpliﬁed
Acute Physiology Score), SOFA (Sepsis-Related Organ Failure Score)
and whether the patient received mechanical ventilation. SAPS and
SOFA were available only if these scores were collected routinely by
the patient's ICU. Characteristics of family members were provided by
respondents in the initial section of the euroQ2 questionnaire and in-
cluded age, gender and relationship to the patient (spouse/partner,
child, or other relationship).
From the original QODD six items were used. The others were
judged irrelevant by Dutch family members as described previously
[6]. New questions were added after interviews and expert panel re-
views [7]. The euroQODD therefore consists of 14 items. Two had binary
(no/yes) response options: did the patient discuss preferences for end-
of-life treatment with a doctor before ICU admission, or during the ICU
stay. An overall rating of end-of-life care was measured with a pseudo-
continuous response scale (0 “worst care possible” to 10 “best care pos-
sible”) but only one respondent provided a rating below 5. Therefore,
we merged this value with the rating of 5, and modeled the result as
an ordered categorical variable with six values (5–10). The remaining
items were ordered categorical variables. Five response categories de-
scribed how often the patient appeared to have pain under control, to
be comfortable on the ventilator, and to retain dignity: none of the
time, a little bit of the time, some of the time, a good bit of the time,
most of the time, all of the time. Five responses were also used to de-
scribe the extent to which the respondent agreed with decisions to
limit treatment: not at all, mostly not, partially, mostly, and totally.
Questions about the participants' role in decision-making regarding
continuing or limiting life sustaining treatment, had ﬁve response op-
tions: doctors without family involvement, doctors after discussion
with family, joint doctor/family decision, family after discussion with
doctors, family without doctor involvement. Five variables offered
three ordinal response options (no, partially, yes): whether the patient
received the needed emotional support, whether the patient received
the needed spiritual support, whether end-of-life care was concordant
with the patient's wishes; whether the patient's life was prolonged un-
necessarily; and whether the family member had a chance to say
goodbye to the patient.
2.6. Statistics
We ﬁrst examined patient and family characteristics, testing for
between-country differences with single-predictor regression models:
probit regression estimated with weighted mean- and variance-
adjusted least squares (WLSMV) for binary characteristics (gender, me-
chanical ventilation); robust linear regression estimated with restricted
maximum likelihood for continuously-scored characteristics (age, ICU
days, SAPS II, SOFA); and multinomial logistic regression estimated
with restricted maximum likelihood for nominal-scale characteristics
(relationship to the patient, reason for admission).We used unclustered
models for patient characteristics; clustered models for family charac-
teristics (family members clustered under patients). P-values for binary
and continuous items were based on Wald's test; those for nominal-
scale variables on likelihood ratio tests. In reportingdescriptive statistics
for continuous measures, we used mean and standard deviation if the
Shapiro-Wilk test for departure from normality had p-value ≥0.05; me-
dian and interquartile range (IQR) if the p-value was b0.05.
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items to family respondents, testing for between-country differences
in accessibility by regressing the binary outcome (0 = no response,
1 = valid response) on country, using probit regression models.
Third, we examined (and tested for between-country differences in)
valid response patterns to the individual euroQODD items. These
models included adjustment for any patient or family characteristics
that were associated with country at p b 0.20. In order to control for
thenumber of euroQODD items compared,we used a Bonferroni correc-
tion for the number of tests (0.05/14), adjusting the level required for a
judgment of statistical signiﬁcance to p b 0.004.
Fourth, using data from themerged countries, we ran a series of fac-
tor analyses to provide an initial evaluation of whether the euroQODD
instrument in its current form contains a set of items that can be com-
bined into a unidimensional construct representing the quality of
dying and death. We evaluated the ﬁt of the resulting models with the
χ2 test of ﬁt, requiring p N 0.05 for a determination of non-signiﬁcant
misﬁt of a model to the observed data. Initial models were based on
merged data from the two participating countries, with subsequent
testing for between-country measurement invariance. Preliminary ex-
ploratory factor analyses (EFA) of 12 of the euroQODD items (excluding
two items measuring actual and preferred roles in decision-making),
ruled out the existence of either a unidimensional or multi-factor
model that made use of the full set of items. Beginning with the 12
items, we then ran a series of single-factor EFA models, using modiﬁca-
tion indices at each step to remove items that contributed tomisﬁt, until
an acceptably ﬁtting unidimensional model was produced. A subse-
quent two-group conﬁrmatory factor analysis (CFA) tested this model
for between-country measurement invariance. Finally, we discussed
methodological and conceptual problems associated with use of the
current euroQODD instrument for building acceptable latent variable
models.
In testing for between-country differences in response patterns, as
well as in all factor analyses, we declared the euroQODD items to be cat-
egorical variables and based our conclusions on probit regression,Table 1
Patient and family characteristicsa.
Total Netherlands
Characteristic Valid
n
Statisticc Valid
n
S
Family (total n) 217 91
Age, mean (SD) 212 56.1 (14.0) 90 5
Male 212 75 (35.4) 90 3
Relationship to patient 213 90
Spouse or partner 79 (37.1) 4
Child 99 (46.5) 3
Other 35 (16.4) 1
Patient (total n) 178 90
Age, median (IQR) 174 73.0 (13.0) 86 7
Male 174 102 (58.6) 86 4
Days in ICU, median (IQR) 173 8.2 (12.0) 86 7
Reason for admission 174 86
Respiratory 76 (43.7) 3
Sepsis 27 (15.5) 1
Cardiovascular 48 (27.6) 2
Other 23 (13.2) 7
Mechanical ventilation 174 160 (92.0) 86 8
SAPS II, mean (SD) 125 59.9 (16.8) 67 5
Admission SOFA, mean (SD) 48 9.1 (3.6) 43 9
IQR = interquartile range, SD = standard deviation, n = sample size.
a P-values shown in boldface signify variables that were used as covariates in tests for betw
b The tests for between-country differences were based on regression models: clustered mo
unclustered models for patients' characteristics. Each regression model included country as th
estimatorswere used: for continuous outcomes (age, days in the ICU, SAPS II, and SOFA scores) l
outcomes (relationship to patient and reason for admission)multinomial logistic regressionwit
ventilation) probit regression with weighted mean- and variance-adjusted least squares estim
those for multinomial regressions were based on likelihood ratio tests.
c Unless otherwise noted, the descriptive statistics presented are n(%). For continuous meas
Shapiro-Wilk test was b0.05, the median and interquartile range are presented as the descriptestimated with robust weighted least squares (WLSMV). Sample de-
scriptives were produced with the Statistical Package for the Social Sci-
ences (SPSS) (IBM, version 21). Between-country comparisons of
patient and family characteristics and euroQODD responses, as well as
factor analyses, were done with Mplus7.4.
2.7. Validity
In our previous paper on the validation of euroQ2 questionnaire we
reported the clinimetric properties of the instrument [7]. A brief sum-
mary is repeated here for clariﬁcation.
2.7.1. Content validity
In the validation phase, relevance and understandability were over-
all very high. For the euroQODD, the median assessment of relevance
was 97% (92–100%) and the median assessment of understandability
was 97% (94–100%).
2.7.2. Test-retest reliability
The average test-retest agreement for the Likert scale responses in
the euroQODD was 0.71 (0.53–0.83). Most of those who had changed
responses from test to retest within the Likert scale had moved only
one “step” up or down the scale or had moved to or from a “Not rele-
vant” response.
2.8. Ethics
In accordance with Dutch law, the study was approved by the IRB
(nWMO 21a) of Medical Centre, which was acknowledged by the insti-
tutional review boards of all participating ICU's. In Denmark, the study
did not need permission from The Regional Committees on Health Re-
search Ethics for Southern Denmark but permission to assess patient
ﬁles was obtained from the Danish National Health Authorities (3-
3013-353/1); the study was registered with the Danish Data Protection
Agency.Denmark Between-country differenceb
tatisticc Valid
n
Statisticc p
126
7.9 (13.8) 122 54.7 (14.0) 0.102
4 (37.8) 122 41 (33.6) 0.526
123 0.037
2 (46.7) 37 (30.1)
4 (37.8) 65 (52.8)
4 (15.6) 21 (17.1)
88
3.5 (16.0) 88 72.5 (13.0) 0.939
6 (53.5) 88 56 (63.6) 0.174
.5 (10.0) 87 9.0 (13.5) 0.281
88 0.135
7 (43.0) 39 (44.3)
7 (19.8) 10 (11.4)
5 (29.1) 23 (26.1)
(8.1) 16 (18.2)
1 (94.2) 88 79 (89.8) 0.287
9.1 (18.5) 58 60.9 (14.6) 0.551
.1 (3.6) 5 9.2 (3.1) 0.965
een-country differences in family respondents' answers to the euroQODD questions.
dels for characteristics of family members (family members clustered under patients) and
e only predictor and the row variable as the outcome. The following regression types and
inear regressionwith restrictedmaximum likelihood estimation; for unordered categorical
h restrictedmaximum likelihood estimation; for binary outcomes (gender andmechanical
ation (WLSMV). P-values for continuous and binary variables were based on Wald's test;
ures an initial test for normality was done, using the total sample; if the p-value for the
ive statistic; if the p-value was ≥0.05, the mean and standard deviation are presented.
Table 2
euroQODD questions.
TOTAL Netherlands Denmark Between-country
differencea
QODD Aspect Valid
n
n (%) Valid
n
n (%) Valid
n
n (%) pb pc
Pain under control 190 70 120
All the time 102 (53.7) 27 (38.6) 75 (62.5) b0.001 b0.001
Most of the time 63 (33.2) 24 (34.3) 39 (32.5)
Good bit of the time 16 (8.4) 12 (17.1) 4 (3.3)
Some of the time 4 (2.1) 2 (2.9) 2 (1.7)
A little bit of the time 3 (1.6) 3 (4.3) 0 (0.0)
None of the time 2 (1.1) 2 (2.9) 0 (0.0)
Comfortable on ventilator 173 70 103 0.431 0.474
All the time 60 (34.7) 26 (37.1) 34 (33.0)
Most of the time 63 (36.4) 18 (25.7) 45 (43.7)
Good bit of the time 21 (12.1) 11 (15.7) 10 (9.7)
Some of the time 13 (7.5) 6 (8.6) 7 (6.8)
A little bit of the time 8 (4.6) 4 (5.7) 4 (3.9)
None of the time 8 (4.6) 5 (7.1) 3 (2.9)
Keeping dignity 185 73 112 0.347 0.287
All the time 94 (50.8) 37 (50.7) 57 (50.9)
Most of the time 55 (29.7) 17 (23.3) 38 (33.9)
Good bit of the time 14 (7.6) 6 (8.2) 8 (7.1)
Some of the time 15 (8.1) 9 (12.3) 6 (5.4)
A little bit of the time 6 (3.2) 3 (4.1) 3 (2.7)
None of the time 1 (0.5) 1 (1.4) 0 (0.0)
Emotional support for patient 159 65 94 0.837 0.918
Yes 129 (81.1) 52 (80.0) 77 (81.9)
Partially 27 (17.0) 12 (18.5) 15 (16.0)
No 3 (1.9) 1 (1.5) 2 (2.1)
Spiritual support for patient 133 60 73 0.023 0.048
Yes 105 (78.9) 42 (70.0) 63 (86.3)
Partially 24 (18.0) 15 (25.0) 9 (12.3)
No 4 (3.0) 3 (5.0) 1 (1.4)
Discussed preferences
Before ICU admission 169 80 89 0.091 0.126
Yes 50(29.6) 29 (36.3) 21 (23.6)
No 119 (70.4) 51 (63.7) 68 (76.4)
In ICU 94 41 53 0.422 0.342
Yes 39 (41.5) 19 (46.3) 20 (37.7)
No 55 (58.5) 22 (53.7) 33 (62.3)
Care concordant with wishes 154 71 83 0.953 0.614
Yes 133 (86.4) 62 (87.3) 71 (85.5)
Partially 16 (10.4) 5 (7.0) 11 (13.3)
No 5 (3.2) 4 (5.6) 1 (1.2)
Life prolonged unnecessarily 204 87 117 0.925 0.878
Yes 9 (4.4) 4 (4.6) 5 (4.3)
Partially 20 (9.8) 8 (9.2) 12 (10.3)
No 175 (85.8) 75 (86.2) 100 (85.5)
Chance to say goodbye 210 89 121 0.692 0.659
Yes 185 (88.1) 78 (87.6) 107 (88.4)
Partially 17 (8.1) 6 (6.7) 11 (9.1)
No 8 (3.8) 5 (5.6) 3 (2.5)
Overall rating of care (0−10) 214 90 124 0.001 0.001
10 97 (45.3) 31 (34.4) 66 (53.2)
9 62 (29.0) 23 (25.6) 39 (31.5)
8 43 (20.1) 28 (31.1) 15 (12.1)
7 5 (2.3) 4 (4.4) 1 (0.8)
6 2 (0.9) 1 (1.1) 1 (0.8)
3,5 5 (2.3) 3 (3.3) 2 (1.6)
Decision Making
Agreed with decision to limit LST 202 86 116 0.318 0.529
Strongly agreed 144 (71.3) 66 (76.7) 78 (67.2)
Agreed 44 (21.8) 14 (16.3) 30 (25.9)
Neither agreed nor disagreed 12 (5.9) 5 (5.8) 7 (6.0)
Disagreed 1 (0.5) 0 (0.0) 1 (0.9)
Strongly disagreed 1 (0.5) 1 (1.2) 0 (0.0)
Actual decision-maker(s) 187 78 109 0.449 0.441
Doctor alone 15 (8.0) 10 (12.8) 5 (4.6)
Doctor after discussing with family 66 (35.3) 20 (25.6) 46 (42.2)
Joint decision: doctor/family 94 (50.3) 47 (60.3) 47 (43.1)
Family after getting information from doctor 11 (5.9) 1 (1.3) 10 (9.2)
Family alone 1 (0.5) 0 (0.0) 1 (0.9)
(continued on next page)
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Table 2 (continued)
TOTAL Netherlands Denmark Between-country
differencea
QODD Aspect Valid
n
n (%) Valid
n
n (%) Valid
n
n (%) pb pc
Preferred decision-maker(s) 192 80 112 0.361 0.345
Doctor alone 3 (1.6) 2 (2.5) 1 (0.9)
Doctor after discussing
with family
61 (31.8) 18 (22.5) 43 (38.4)
Joint decision: doctor/family 117 (60.9) 57 (71.3) 60 (53.6)
Family after getting
information from doctor
11 (5.7) 3 (3.8) 8 (7.1)
Family alone 0 (0.0) 0 (0.0) 0 (0.0)
LST = life-sustaining treatment.
a All variables were deﬁned as ordered categorical variables, with the tests for between-country differences based on probit regression estimated with weighted mean- and variance-
adjusted least squares (WLMSV) and the p-values based on Wald tests. All models clustered family members under patients.
b These p-values are for models containing only the country indicator as predictor and the QODD aspect as the outcome. Values in boldface are those that met the cutoff for statistical
signiﬁcance using the Bonferroni-corrected value.
c These p-values are for models that adjusted the association between country and the QODD aspect for possible confounding by the family respondent's age and relationship to the
patient and for the patient's gender and reason for admission. Sample sizes for the adjustedmodel were reduced by 3 to 9 cases, depending upon the outcome, because of cases with valid
outcome responses but missing data on one or more of the covariates. Values in boldface are those that met the cutoff for statistical signiﬁcance using the Bonferroni-corrected value.
Table 3
Unidimensional QODD factor, standardized indicator loadingsa.
Indicator TOTALb Denmarkc Netherlandsc
Pain control 0.761 0.726 0.801
Ventilator comfort 0.817 0.711 0.890
Dignity 0.773 0.672 0.900
Spiritual support 0.765 0.802 0.711
Life not unnecessarily prolonged 0.300 0.234 0.412
End-of-life care according to patient's wishes 0.407 0.314 0.516
a Factor analyses were based on probit regression, with all indicators declared as or-
dered categorical variables. All loadings were statistically signiﬁcant.
b Based on an EFA model with data from the two countries combined.
c Standardized loadings, based on a two-group CFA model with unstandardized load-
ings and thresholds constrained to equality between countries.
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3.1. Sample
We sent the euroQ2 to 1485 family members, of whom 1077 com-
pleted and returned the questionnaire (response rate 72.5%). Of these,
217 family members (representing 174 patients) completed the
euroQODD. Respondents included 126 family members from Denmark
and 91 from The Netherlands. Table 1 summarizes the characteristics
of the responding family members, and demographic and ICU informa-
tion about their associated patients. Family members were, on average,
middle-aged, and the majority were women. Most were the patient's
child (46%) or partner (37%). Patientswere typically older than the fam-
ily respondents, and most were men. The median length of stay in the
ICU was 8 days, with a majority of the patients receiving mechanical
ventilation during ICU treatment.
Table 2 summarizes responses to the euroQODD questions. In gener-
al, family members were highly satisﬁed with the emotional support
provided to the patient, the concordance between the patient's prefer-
ences for end-of-life care and the care that was provided, and the possi-
bilities to say goodbye to their loved one, with positive ratings from
N80% of the respondents. In addition, a large majority (86%) indicated
a feeling that the patient's life had not been unnecessarily prolonged. Al-
though preferences regarding end-of-life care were discussedmore fre-
quently after ICU admission than before admission, such discussions
occurred in aminority of cases at each time point, and 57.5% of the fam-
ily members with valid responses to both questions indicated that such
a discussion had never occurred: 50.0% in the Netherlands, and 63.8% in
Denmark (data not shown). After adjustment for the family
respondent's age and relationship to the patient and for the patient's
gender and reason for admission, there were signiﬁcant between-
country differences on only two items: pain control and the overall rat-
ing of care, with family members from Denmark giving higher ratings
on both aspects (p ≤ 0.001).
Of the 217 respondents, 212 indicated that decisions were made to
limit care, and 187 gave valid responses to a question attributing the de-
cision to doctors and/or the family. The majority (92.0%) of these re-
spondents felt that they had been included to some extent in the
decision-making process, with over half (50.3%) perceiving truly shared
decision making. Of the 177 respondents who stated both their actual
and preferred role, 132 (74.6%) were happy with their actual role, 32
(18.1%) would have preferred more involvement, and 13 (7.3%) would
have preferred less involvement than they experienced. Almost no
one (1.6%) wanted the doctor to make the decision without involving
the family, and no respondents reported wanting to make the decisionthemselves, without the doctor's input. A large majority (93% of those
who provided ratings and for whom the question was applicable) indi-
cated either agreement or strong agreement with the decision that was
made to limit treatment.
By and large, family members had little difﬁculty answering the 14
euroQODD questions. In the combined samples, 81.8% of the questions
received valid responses, and only 18.8% were excluded from analyses
because of missing data (primarily the result of questions that were in-
applicable for a family member or to which the family member didn't
know the answer). However, there were four questions for which
N25% of the responses were unusable: (1) patient discussion of end-
of-life care preferences after ICU admission (56.7% missing, with 39.6%
inapplicable [patient couldn't communicate]; 14.3% don't know, 2.8%
no response), (2) provision of adequate spiritual support (38.7% miss-
ing, with 35.5% don't know and 3.2% no answer), (3) concordance be-
tween patient's care preferences and care provided (29.0% missing,
with 25.3% don't know and 3.7% no response), and (4) provision of ad-
equate emotional support (26.7% missing, with 24.0% don't know and
2.8% no answer). There were signiﬁcant between-country differences
in the amount ofmissing data on two items: pain control (23.1%missing
in The Netherlands; 4.8% in Denmark) and patient discussion of care
preferences before ICU admission (12.1% missing in The Netherlands;
29.4% in Denmark).
3.2. Unidimensional construct representing the overall quality of dying and
death (QODD)
An initial 12-indicator unidimensional EFA model showed signiﬁcant
misﬁt to the observed data: χ2 = 360.727, 54df, p= 0.0000; RMSEA =
0.162, 90% CI = 0.147–0.178, probability that RMSEA ≤ 0.05 = 0.000;
CFI = 0.763, TLI = 0.711. Removal of six indicators that contributed to
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signiﬁcant and with good model ﬁt: χ2 = 6.522, 9df, p = 0.6868;
RMSEA = 0.000, 90% CI = 0.000–0.061, probability that RMSEA ≤
0.05 = 0.908; CFI = 1.000, TLI = 1.008 (Table 3, TOTAL column).
A two-groupmodel of the QODD construct, with unstandardized in-
dicator loadings and thresholds constrained to equality between coun-
tries, provided evidence of between-country measurement invariance:
χ2 = 39.579, 33df, p = 0.1998; RMSEA = 0.043, 90% CI =
0.000–0.087, probability that RMSEA ≤ 0.05 = 0.556; CFI = 0.990,
TLI = 0.991 (standardized loadings for the separate countries shown
in Table 3). The two countries did not differ signiﬁcantly with regard
to mean levels on the QODD construct (unstandardized level for
Denmark ﬁxed at 0.000, estimated unstandardized level for the
Netherlands =−0.225, p= 0.247). Although all indicator loadings in
both countries were statistically signiﬁcant, loadings for prolongation
of life and care concordant with patients' wishes were weak, with R2
values suggesting that the latent construct explained little of the esti-
mated variance in those variables in either country. R2 values for the in-
dicators in Denmark were as follows: pain control (0.527, p b 0.001),
ventilator comfort (0.506, p b 0.001), dignity (0.452, p b 0.001), spiritual
support (0.643, p b 0.001), prolongation of life (0.055, p= 0.228), and
care concordant with patient wishes (0.099, p = 0.115). In Denmark
the corresponding values were as follows: 0.641 (p b 0.001), 0.793
(p b 0.001), 0.810 (p b 0.001), 0.506 (p b 0.001), 0.170 (p = 0.209),
and 0.267 (p= 0.028).
Although the QODD construct showed good ﬁt to the data, and the
demonstration of between-country measurement invariance suggested
its appropriateness for between-country comparisons, it includes a type
of model misspeciﬁcation that is frequently made in research using
structural equation modeling techniques and that is unavoidable with
the current euroQODD instrument, taken alone. The model is based on
the premise that the six indicators are “reﬂective” indicators
(i.e., effects of the quality of dying and death), when they would be
more accurately considered causal indicators (i.e., contributors to the
quality of dying and death) [8-10]. In order for a model containing a la-
tent variable that is measured with causal indicators to be statistically
identiﬁable, the latent variable must have at least two outcomes (either
two reﬂective indicators, in addition to the causal indicators, or two
more distal outcomes). The euroQODD currently lacks these additional
items.
4. Discussion
In this study, the euroQODD questionnaire provided relatively high
overall ratings of end-of-life care for patients dying in Danish or Dutch
ICUs by their family members, with very few signiﬁcant differences be-
tween countries. In general, family members perceived that care was in
line with patients' wishes, and only a small minority reported that life
was prolonged unnecessarily. These ﬁndings are similar to those from
studies that have been conducted in other countries, including the US
[11,12]. Two items varied signiﬁcantly between Denmark and the
Netherlands with Danish participants providing higher endorsements
and ratings: 1) perceived pain control; and 2) overall rating of care.
This ﬁnding suggests possible opportunities for improvement in care
in the Netherlands. Prior studies have identiﬁed the importance of
symptom control for patients and family members [13,14], and overall
assessments have been used as a reliable measure of quality of care
[15-17]. However, when considering differences between countries, it
is important to take into account how expectations for healthcare and
healthcare providers may vary and the effect of this variability on as-
sessments is unknown [18-21].
The high scores correlated well with previously published research
on end-of-life care in general [11,12]. Previous studies suggest that sup-
port for shared decision-making may be an important factor contribut-
ing to high scores of end-of-life care [22]. Our data support this
hypothesis. Both Denmark and the Netherlands have legislation and atradition whereby the medical team make important decisions if pa-
tients do not have decision-making capacity. Families cannot make de-
cisions on behalf of the patient but may contribute information about
patients' wishes and values. Interestingly, families' perceptions did not
reﬂect this legislation. In the Netherlands, N60% of the family members
perceived they had participated equally with doctors in decision-
making while another 26% perceived that the doctor made the decision
after consulting them. In Denmark, the portion of the families that felt
they shared in decision-making was somewhat smaller (43%), with an
additional 42% perceiving that the doctor made the decisions after con-
sulting the family. Importantly, the majority of family members in both
countries reported preferring a shared decision-making approach
(slightly higher in the Netherlands at 71% compared to 54% in
Denmark. Our ﬁndings suggest that relatives would like to be more in-
volved in decision-making than they currently are. These ﬁndings sup-
port the hypothesis of an ongoing transition towards shared decision-
making [23,24]. This may mark a societal shift towards shared
decision-making in Denmark and the Netherlands that is not currently
reﬂected by the laws in these countries.
We also used our data to examine whether the euroQODD (either in
its entirety or with a subset of items)measures a construct representing
the quality of dying and death. The original US-developed QODD survey
was designed to measure six theoretical domains: symptom and per-
sonal care, preparation for death, moment of death, family, treatment
preferences and whole person concerns. However, a six-factor model
representing these six domains did not provide adequate ﬁt to data
from the US. Although a four-factor model using a subset of the original
QODD items provided adequate ﬁt to community data from the US [25],
several of the items in that study had signiﬁcantmissing data in a study
from Denmark and the Netherlands and were removed from the ﬁnal
euroQODD instrument. With the current data, we located a unidimen-
sional construct, measured with six items, that showed good ﬁt to the
data and evidence ofmeasurement invariance between countries. How-
ever, that construct misspeciﬁed the six items as reﬂective indicators.
Addition of actual reﬂective indicators of the quality of dying and
death to the euroQODD will be needed if the instrument, standing
alone, is to serve as a vehicle for measuring a latent construct
representing the overall quality-of-dying-and-death.
Recently, a French 15-item CAESAR questionnaire was developed
and validated for use among family of critically ill patients who died in
the ICU. The authors report one overall score from CAESAR with three
domains: patient, interaction with and around the patient and family
needs, and satisfaction [17]. Eleven of the questions are similar to the
euroQODD. In addition, CAESAR includes questions about communica-
tion which we did not include in the euroQODD, although such items
were included as a measure of satisfaction with care in the euroFS-
ICU. In the euroQODD, questions about decision making are included
which are not part of CAESAR. Low CAESAR scoreswere shown to corre-
late with higher levels of complicated grief or PTSD. We did not ﬁnd an
association between low scores on euroQ2 and PTSD or depression, as
reported previously [7]. Further studies are needed to assess whether
the overall score provided by the CAESAR is unidimensional and how
CAESAR and the euroQODD or euroFS-ICU compare in order to address
the call for the development of robust quality metrics to improve end-
of-life care for critically ill patients [26].
Additional testing of the euroQ2 questionnaire in countries from
other regions, including Southern and Eastern Europe, is currently un-
derway. This is important for future development. Part of that testing
will include adaptation of the questionnaire with additional questions
that may improve the psychometric characteristics of the instrument.
4.1. Strengths and limitations
A relative strength of this study was the enrollment of N1000 family
members from two countries, of which 217 completed the euroQODD.
Furthermore, family members were related to patients who were
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areas, a diversity that increases the generalizability of results. The high
response rate and small number of unanswered questions are addition-
al strengths. Although response rate data is only available for the entire
population and the Dutch euroQODD cohort, which are both high, these
data are not available for the Danish euroQODD cohort.
There are also important limitations. Despite the high number of
participants in the overall study, far fewer respondents were eligible
for completing the QODD portion of the questionnaire. This smaller
sample, drawn from two relatively limited geographic areas, decreases
one's conﬁdence in the generalizability of the results.
5. Conclusion
The euroQODD part of the euroQ2 project provides information
about families' experiences with dying and death of their family mem-
ber in the ICU. The perceived quality of end-of-life care is relatively
high, and a majority of participants believed that care at the end-of-
life was in accord with patient wishes. However, we identiﬁed some
areas for improvement. Importantly, family members desired a higher
level of participation in decision-making than they perceived occurring.
There was also room for improvement in pain and symptom control. A
small group of relatives found that the patient's life was unnecessarily
prolonged, whichmay also represent an area for improvement. Psycho-
metric assessment suggests that this version of the euroQODDwarrants
continued development and additional study as an outcome for pallia-
tive care interventions in the ICU. The euroQ2 – a pairing of the
euroFS-ICU and the euroQODD – provides a promising new instrument
to assess ICU care and identify areas for improvement.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.jcrc.2017.12.015.
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